Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06732726 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Padua Prediction Score for VTE Risk in Thoracic Surgery Patients

Study acronym: DVT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Jul 1, 2025 → Jul 1, 2027
See other at-risk trials from Al-Nahrain University

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jul 1, 2025 to Jul 1, 2027 Show 5 more changesShow less
    • Recruitment opened
    • Study completion pushed from Jul 15, 2025 to Jul 15, 2027
    • Eligibility criteria expanded, about 11 words
    • Site details revised
    • Publications: details revised at 2 of 2 entries
  2. Notable Start date: Feb 20, 2025 to Apr 20, 2025
    • Primary completion date: Apr 1, 2025 to Jul 1, 2025
    • Study completion date: Apr 15, 2025 to Jul 15, 2025
    v4
  3. Notable Start date: Dec 20, 2024 to Feb 20, 2025
    • Primary completion date: Mar 1, 2025 to Apr 1, 2025
    • Study completion date: Mar 15, 2025 to Apr 15, 2025
    • Site contact updated
    v3
  4. Notable Primary endpoints revised (2)
    • Secondary endpoints revised (2)
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to assess the predictive accuracy of the Padua Prediction Score (PPS) for venous thromboembolism (VTE) risk in thoracic surgery patients. The study aims to answer the following question: Does the PPS provide a more accurate prediction of VTE risk? Participants will: Have their VTE risk assessed using the PPS during their hospital admission.
Trial Details
NCT Number NCT06732726
Lead Sponsor Al-Nahrain University
Conditions
(from sponsor)
DVT - Deep Vein Thrombosis, VTE (Venous Thromboembolism)
Related terms Venous Thromboembolism, Venous Thrombosis
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov